Zurab Nadareishvili1,2, Marie Luby1, Richard Leigh1, Jignesh Shah1,3, John K Lynch1, Amie W Hsia1,4, Richard T Benson1,4, Lawrence L Latour1. 1. Section on Stroke Diagnostics and Therapeutics, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD. 2. Suburban Hospital NIH Stroke Center, Johns Hopkins Medicine, Bethesda, MD. 3. Department of Neurology, University of Louisville, Louisville, KY. 4. Medstar Washington Hospital Stroke Center, Washington, DC.
Abstract
BACKGROUND AND PURPOSE: Blood-brain barrier (BBB) disruption detected on magnetic resonance imaging (MRI) in acute ischemic stroke as a hyperintense acute reperfusion marker (HARM) is associated with upregulation of matrix metalloproteinase-9 (MMP-9). Although activated leukocytes, including monocytes, are the main source of MMPs, limited data exist to support relationship between leukocyte activation and BBB disruption in patients with acute ischemic stroke. The goal of this study is to investigate the relationship between neutrophils, lymphocytes, and monocytes with BBB disruption detected as HARM (+) in patients with acute ischemic stroke. METHODS: We conducted a retrospective analysis of prospectively collected data in patients who did not receive any reperfusion therapy with acute (<12 hours) ischemic stroke. MRI scans were obtained at baseline, 24 hours, and 5 days. HARM was evaluated on the 24-hour follow-up scan. RESULTS: Thirty-three patients were studied. HARM was detected in 27% of patients. Median volumes of baseline perfusion (mean transit time [MTT]) deficit (219.4 mL vs. 158.4 mL, P = .029) and DWI infarct growth at 24 hours (18.50 mL vs. .14 mL, P = .017), as well as the median absolute numbers (1 × 103 /mm3 ) of monocytes, were significantly higher in HARM (+) versus HARM (-) patients (0.9 vs. 0.6, p = 0.011). CONCLUSION: Increased monocyte count associated with HARM supports importance of systemic inflammation in BBB disruption in acute ischemic stroke.
BACKGROUND AND PURPOSE: Blood-brain barrier (BBB) disruption detected on magnetic resonance imaging (MRI) in acute ischemic stroke as a hyperintense acute reperfusion marker (HARM) is associated with upregulation of matrix metalloproteinase-9 (MMP-9). Although activated leukocytes, including monocytes, are the main source of MMPs, limited data exist to support relationship between leukocyte activation and BBB disruption in patients with acute ischemic stroke. The goal of this study is to investigate the relationship between neutrophils, lymphocytes, and monocytes with BBB disruption detected as HARM (+) in patients with acute ischemic stroke. METHODS: We conducted a retrospective analysis of prospectively collected data in patients who did not receive any reperfusion therapy with acute (<12 hours) ischemic stroke. MRI scans were obtained at baseline, 24 hours, and 5 days. HARM was evaluated on the 24-hour follow-up scan. RESULTS: Thirty-three patients were studied. HARM was detected in 27% of patients. Median volumes of baseline perfusion (mean transit time [MTT]) deficit (219.4 mL vs. 158.4 mL, P = .029) and DWI infarct growth at 24 hours (18.50 mL vs. .14 mL, P = .017), as well as the median absolute numbers (1 × 103 /mm3 ) of monocytes, were significantly higher in HARM (+) versus HARM (-) patients (0.9 vs. 0.6, p = 0.011). CONCLUSION: Increased monocyte count associated with HARM supports importance of systemic inflammation in BBB disruption in acute ischemic stroke.
Authors: Michal Rozanski; Martin Ebinger; Wolf U Schmidt; Benjamin Hotter; Sandra Pittl; Peter U Heuschmann; Jan G Jungehuelsing; Jochen B Fiebach Journal: Eur Radiol Date: 2010-07-21 Impact factor: 5.315
Authors: Y Dörffel; C Lätsch; B Stuhlmüller; S Schreiber; S Scholze; G R Burmester; J Scholze Journal: Hypertension Date: 1999-07 Impact factor: 10.190
Authors: Philipp Eisele; Martin Griebe; Kristina Szabo; Marc E Wolf; Angelika Alonso; Britta Engelhardt; Michael G Hennerici; Achim Gass Journal: Neurology Date: 2015-01-23 Impact factor: 9.910
Authors: Taura L Barr; Lawrence L Latour; Kyung-Yul Lee; Timothy J Schaewe; Marie Luby; George S Chang; Ziad El-Zammar; Shaista Alam; John M Hallenbeck; Chelsea S Kidwell; Steven Warach Journal: Stroke Date: 2009-12-24 Impact factor: 7.914
Authors: Marie Luby; Amie W Hsia; Zurab Nadareishvili; Kaylie Cullison; Noorie Pednekar; Malik Muhammad Adil; Lawrence L Latour Journal: Stroke Date: 2019-06-26 Impact factor: 7.914
Authors: Malik M Adil; Marie Luby; John K Lynch; Amie W Hsia; Chandni P Kalaria; Zurab Nadareishvili; Lawrence L Latour; Richard Leigh Journal: J Stroke Cerebrovasc Dis Date: 2020-07-04 Impact factor: 2.677
Authors: Panagiotis Mastorakos; Nicole Mihelson; Marie Luby; Scott R Burks; Kory Johnson; Amie W Hsia; Jaclyn Witko; Joseph A Frank; Lawrence Latour; Dorian B McGavern Journal: Nat Neurosci Date: 2021-01-18 Impact factor: 24.884
Authors: Luigi Francesco Saccaro; Imen Bekri; Maxime De Malherbe; Intissar Hmida; Fernando Pico Journal: BMC Neurol Date: 2022-04-14 Impact factor: 2.474
Authors: Whitney M Freeze; Merel van der Thiel; Jeroen de Bresser; Catharina J M Klijn; Ellis S van Etten; Jacobus F A Jansen; Louise van der Weerd; Heidi I L Jacobs; Walter H Backes; Susanne J van Veluw Journal: Neuroimage Clin Date: 2020-10-02 Impact factor: 4.881
Authors: Tomasz Urbanowicz; Michał Michalak; Anna Olasińska-Wiśniewska; Anna Witkowska; Michał Rodzki; Ewelina Błażejowska; Aleksandra Gąsecka; Bartłomiej Perek; Marek Jemielity Journal: Medicina (Kaunas) Date: 2021-12-03 Impact factor: 2.430